Source: gtrnews.com (Greater Tulsa Reporter Newspapers)
Published: March 04, 2013
Cancer Treatment Centers of America in Tulsa (CTCA) announces the addition of Joseph P. Lynch, MD, MS as medical director of the hospital’s new stem cell transplant and cell therapy program. The CTCA stem cell transplant unit is expected to open in early March and will be the third in the state.
Through this new service offered at the Tulsa hospital, patients with malignant blood cancers will now be able to complete treatment through bone marrow transplant on-site while keeping their continuity of care with CTCA. This service will be available to patients with hematology malignancies such as chronic and acute leukemia, Hodgkin’s and Non-Hodgkin’s lymphoma, multiple myeloma, and any other malignant blood cancers.